Unknown

Dataset Information

0

Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma.


ABSTRACT: Glioblastoma recurrence after aggressive therapy typically occurs within six months, and patients inevitably succumb to their disease. Tumor recurrence is driven by a subpopulation of cancer stem cells in glioblastoma (glioblastoma stem-like cells, GSCs), which exhibit resistance to cytotoxic therapies, compared to their non-stem-cell counterparts. Here, we show that the Cox-2 and Wnt signaling pathways are aberrantly activated in GSCs and interact to maintain the cancer stem cell identity. Cox-2 stimulates GSC self-renewal and proliferation through prostaglandin E2 (PGE2), which in turn activates the Wnt signaling pathway. Wnt signaling underlies PGE2-induced GSC self-renewal and independently directs GSC self-renewal and proliferation. Inhibition of PGE2 enhances the effect of temozolomide on GSCs, but affords only a modest survival advantage in a xenograft model in the setting of COX-independent Wnt activation. Our findings uncover an aberrant positive feedback interaction between the Cox-2/PGE2 and Wnt pathways that mediates the stem-like state in glioblastoma.

SUBMITTER: Wu M 

PROVIDER: S-EPMC5669884 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma.

Wu Megan M   Guan Jennifer J   Li Chris C   Gunter Simon S   Nusrat Labeeba L   Ng Sheena S   Dhand Karan K   Morshead Cindi C   Kim Albert A   Das Sunit S  

Oncotarget 20170717 47


Glioblastoma recurrence after aggressive therapy typically occurs within six months, and patients inevitably succumb to their disease. Tumor recurrence is driven by a subpopulation of cancer stem cells in glioblastoma (glioblastoma stem-like cells, GSCs), which exhibit resistance to cytotoxic therapies, compared to their non-stem-cell counterparts. Here, we show that the Cox-2 and Wnt signaling pathways are aberrantly activated in GSCs and interact to maintain the cancer stem cell identity. Cox-  ...[more]

Similar Datasets

| S-EPMC6180579 | biostudies-literature
| S-SCDT-10_1038-S44318-024-00276-1 | biostudies-other
| S-EPMC5919960 | biostudies-literature
| S-EPMC3548587 | biostudies-literature
| S-EPMC8091781 | biostudies-literature
| S-EPMC4585991 | biostudies-other
| S-EPMC6691379 | biostudies-literature
| S-EPMC5997265 | biostudies-literature
| S-EPMC6499328 | biostudies-literature
| S-EPMC5239505 | biostudies-literature